Skip to main content
Fig. 1 | Journal of Ovarian Research

Fig. 1

From: Serum amyloid a, a potential biomarker both in serum and tissue, correlates with ovarian cancer progression

Fig. 1

SAA is overexpressed in ovarian cancer. a. SAA is overexpression in ovarian cancer samples (109 cases) compared with adjacent normal tissue samples (37 cases) in Oncomine profiles, P = 0.008, Wilcoxon-Signed rank test. b. SAA expression increased significantly in 32 paired ovarian tumor tissues (Tumor) and their adjunct normal tissues (Adjacent) in Oncomine profiles. Data are presented as the Mean ± SD, Adjacent (0.575 ± 0.698), Tumor (2.450 ± 0.982). C. Kaplan-Meier survival curves demonstrated that the overall survival of patients with high expression of SAA was not significantly different from those with low SAA expression in the same profiles, P = 0.8533, Log-rank (Mantel-Cox) test

Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us